As was reported recently in an immunocompromised patient with chronic lymphocytic leukemia (CLL) [68], prostate cancer patients who have very high TMPRSS2 in their cancer may be especially vulnerable and may constantly shed the virus. This evidence concerns the gene TMPRSS2 and cancer.